FTC settlement with Caremark aims to cap insulin copays and boost pharmacy transparency—what’s next
The FTC says a proposed consent order with Caremark and Zinc would cap insulin copays and add pricing transparency—public comments come first.
The FTC says a proposed consent order with Caremark and Zinc would cap insulin copays and add pricing transparency—public comments come first.
